Incidence and treatment of feline renal lymphoma: 27 cases
- PMID: 33464143
- PMCID: PMC11197130
- DOI: 10.1177/1098612X20984363
Incidence and treatment of feline renal lymphoma: 27 cases
Abstract
Objectives: Lymphoma is the most common feline hematopoietic malignancy. Incidence of renal lymphoma has not been reported as a subset of a large population of feline lymphoma cases. Previous studies have reported renal lymphoma as both a singular entity as well as a component of multicentric disease. The clinical presentation, diagnostic evaluation, therapy and outcomes related to renal lymphoma have not been reported since Mooney et al in 1987. This retrospective study aimed to describe the incidence of renal lymphoma, clinical signs, treatment and survival.
Methods: Using a database of cats diagnosed with lymphoma between January 2008 and October 2017, cats with renal lymphoma were selected for further analysis. Cases were retrospectively staged according to Mooney et al (1987) and Gabor et al (1998). Data collected included age, clinical signs, clinicopathologic data, diagnostic imaging findings, lymphoma diagnostic method(s), treatment protocol(s) and survival time. Analyses comparing median survival based on therapy administered, renal lymphoma vs multicentric lymphoma, central nervous system involvement, presence of azotemia, anemia and International Renal Interest Society (IRIS) stage at diagnosis were performed.
Results: From a population of 740 cats with lymphoma, 27 cats had renal lymphoma (incidence, 3.6%), and 14 of those cats had multicentric lymphoma. Fewer stage IV and V cases were identified in this data set compared with Mooney et al; however, not all cats were completely staged. Median survival (range) for cats receiving corticosteroids alone compared with those receiving an L-CHOP (L-asparaginase, vincristine, cyclophosphamide, doxorubicin, prednisolone)-based protocol was 50 days (20-1027 days) in the corticosteroid group and 203 days (44-2364 days) for the L-CHOP group (P = 0.753) for cats that died secondary to lymphoma.
Conclusions and relevance: Neither clinical stage nor other factors were predictive of survival. Prospective studies are required to determine the optimal chemotherapy protocol.
Keywords: Lymphoma; azotemia; incidence; renal; reverse stage migration.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Mooney SC, Hayes AA, Matus RE. Renal lymphoma in cats: 28 cases (1977–1984). J Am Vet Med Assoc 1987; 191: 1473–1477. - PubMed
-
- Gabor LJ, Canfield PJ. Clinical and anatomical features of lymphosarcoma in 118 cats. Aust Vet J 1998; 76: 725–732. - PubMed
-
- Taylor SS, Goodfellow MR, Browne WJ. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. J Small Anim Pract 2009; 50: 584–592. - PubMed
-
- Vail DM, Moore AS, Ogilvie GK. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. J Vet Intern Med 1998; 12: 349–354. - PubMed
-
- Mooney SC, Hayes AA. Lymphoma in the cat: an approach to diagnosis and management. Semin Vet Med Surg 1986; 1: 51–57. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
